Current status of Fe-based MOFs in biomedical applications

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Nanoparticle-based drug delivery systems are gaining traction for cancer therapy.
• Metal-organic frameworks (MOFs) offer advantages over conventional carriers with high drug loading and porous structures.
• Fe(III)-based MOFs exhibit biocompatibility, good drug loading, Fenton reactivity, and superparamagnetism.

Purpose of the Study:

• To summarize the applications of Fe(III)-based MOFs in cancer therapy.
• To explore their potential in chemodynamic therapy, photothermal therapy, and MRI.
• To suggest new strategies and identify challenges in this research area.

Main Methods:

• Literature review of Fe(III)-based MOFs in cancer therapy.
• Analysis of their properties for drug delivery and diagnostics.
• Synthesis and characterization of MOFs for therapeutic applications.

Main Results:

• Fe(III)-based MOFs demonstrate significant potential in chemodynamic therapy via Fenton reactivity.
• Their superparamagnetic properties enable applications in photothermal therapy and MRI.
• These nanomaterials enhance therapeutic efficiency and bioavailability in targeted cancer treatment.

Conclusions:

• Fe(III)-based MOFs are versatile platforms for multimodal cancer therapy and diagnostics.
• Further research is needed to overcome challenges and realize their full clinical potential.
• This review provides a roadmap for developing novel Fe(III)-based MOF strategies.